Expert: Isotope crisis could impact cancer trials

06/14/2009 | Reuters

The ongoing isotope shortage could affect clinical trials for cancer drugs as patients might decide to drop out because of delayed scans, said Dr. Peter Conti of the University of Southern California in Los Angeles. Doctors also are prioritizing the most urgent scans, usually heart scans, and the tests to monitor cancer spread have been set aside, Conti said. A survey of members of the Society of Nuclear Medicine showed 60% already have postponed tests and that 31% have canceled some procedures.

View Full Article in:


Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Sr. Regulatory Specialist, Biotech Center of Expertise
BASF, The Chemical Co.
San Diego, CA
Food Lawyer
Wayzata, MN
Meridian Health Plan
Detroit, MI
Assistant Vice President - Dental Director
Bridgewater, NJ
Vice President of Finance
Urban Health Plan, Inc.
Bronx, NY